top of page

Publications

March 2021

"Pain is Subjective": A Mixed-Methods Study of Provider Attitudes and Practices Regarding Pain Management in Sickle Cell Disease Across Three Countries.”

Stewart, Kearsley A., Monika Parshad-Asnani, Ambroise Wonkam, John Bollinger, Valentina Ngo Bitoungui, Edmond Wonkam-Tingang, Jill Powell, et al.

--

“A Protocol to Assess Feasibility, Acceptability, and Usability of Mobile Technology for Symptom Management in Pediatric Transplant Patients.”

Vaughn, Jacqueline, Erika Summers-Goeckerman, Ryan J. Shaw, and Nirmish Shah.

August 3, 2018

“Abstract Animations for the Communication and Assessment of Pain in Adults: Cross-Sectional Feasibility Study.”

Jonassaint, Charles R., Nema Rao, Alex Sciuto, Galen E. Switzer, Laura De Castro, Gregory J. Kato, Jude C. Jonassaint, Zakia Hammal, Nirmish Shah, and Ajay Wasan.

2017

“Advances in iron chelation therapy: transitioning to a new oral formulation.”

Shah, Nirmish R., Menaka Bhor, Dominick Latremouille-Viau, Vikash Kumar Sharma, Gary A. Puckrein, Patrick Gagnon-Sanschagrin, Ankur Khare, et al.

January 2021

“An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.”

Bulgin, Dominique, Emily Bonnabeau, Angie Alexander, Emilia Frederick, Gary Rains, Nirmish Shah, Matthew Young, and Paula Tanabe.

January 2017

“Attitudes of Primary Care Physicians Toward Sickle Cell Disease Care, Guidelines, and Comanaging Hydroxyurea With a Specialist.”

Lunyera, Joseph, Charles Jonassaint, Jude Jonassaint, and Nirmish Shah.

--

“A Cross-sectional Feasibility Study Testing the Use of Abstract Animations for the Communication and Assessment of Pain (Preprint),”

Jonassaint, Charles, Nema Rao, Alex Sciuto, Galen Switzer, Laura De Castro, Gregory J. Kato, Jude H. Jonassaint, Zakia Hammal, Nirmish Shah, and Ajay Wasan.

November 2021

“A reanalysis of pain crises data from the pivotal l-glutamine in sickle cell disease trial.”

Zaidi, Ahmar U., Jeremie Estepp, Nirmish Shah, Salam Alkindi, Hatoon Ezzat, Hung Lam, and Caterina P. Minniti.

April 2021

“Adherence to Iron Chelation Therapy with Deferasirox Formulations among Patients with Sickle Cell Disease and β-thalassemia.”

Oyedeji, Charity I., Regina D. Crawford, and Nirmish Shah.

January 2021

“An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.”

Bulgin, Dominique, Emily Bonnabeau, Angie Alexander, Emilia Frederick, Gary Rains, Nirmish Shah, Matthew Young, and Paula Tanabe.

February 2021

“Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients.”

Racioppi, Alessandro, Tara Dalton, Sendhilnathan Ramalingam, Kristi Romero, Yi Ren, Lauren Bohannon, Consuelo Arellano, et al.

January 2021

“Awareness and Use of the Sickle Cell Disease Toolbox by Primary Care Providers in North Carolina.”

Ibemere, Stephanie O., Paula Tanabe, Emily Bonnabeau, Gary Rains, Kern Eason, Marian F. Earls, and Nirmish Shah.

  • Twitter
  • White LinkedIn Icon

© 2023 by Dr. Nirmish Shah

bottom of page